Josh Levitsky

Grants

Grants per year 2004 2008 2013 2015 2016 2028

• 9 Active
• 42 Finished

Grants per year

Search results

• Finished

  Proteomic Predictors of Chronic Kidney Disease in Liver Transplant Recipients

  Levitsky, J. & Zhao, L.

  National Institute of Allergy and Infectious Diseases

  8/1/14 → 1/31/18

  Project: Research project

  • kidneys 100%
  • diseases 54%
  • Chronic Kidney Disease 54%
  • Chronic Kidney Failure 54%
  • transplants 50%

• Continuation Funding for the Immune Tolerance Network [ITN030ST (A-WISH)]

  Levitsky, J.

  Benaroya Research Institute at Virginia Mason, National Institute of Allergy and Infectious Diseases

  5/1/14 → 5/31/16

  Project: Research project

  • immune tolerance 100%
  • Immunological Tolerance 100%
  • Immune Tolerance 100%
  • diseases 57%
  • Combination Therapy 57%

• HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network-A Longitudinal, Observational Study

  Levitsky, J.

  University of Florida

  3/28/14 → 3/28/22

  Project: Research project

• RFHE4043PK: A Sub-study to Evaluate the Pharmacokinetics of Rifaximin in Subjects with Severe Hepatic Impairment and Overt Hepatic Encephalopathy

  Levitsky, J.

  Valeant Pharmaceuticals North America LLC, Salix Pharmaceuticals, Inc.

  5/3/13 → 5/3/16

  Project: Research project

• Prot# M12-999: Open-label, Single Arm, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered with Ribavirin (RBV) in Adult Liver Transplant Recipients with Genotype

  Levitsky, J.

  AbbVie Inc.

  4/15/13 → 4/15/19

  Project: Research project

• RFHE4043: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Rifaximin 550 mg in Subjects with Severe Hepatic Impairment and Overt Hepatic Encephalopathy

  Ganger, D. R. & Levitsky, J.

  Valeant Pharmaceuticals North America LLC, Salix Pharmaceuticals, Inc.

  3/12/13 → 12/31/15

  Project: Research project

• Protocol # CRAD001AUSNC10T: The Effects of Everolimus with and without Tacrolimus and Mycophenolic Acid on Donor-Specific Tregs in the Treg-MLR

  Levitsky, J. & Mathew, J.

  Novartis Pharmaceuticals Corporation

  1/11/13 → 12/19/14

  Project: Research project

• Delayed Chimerism Induction in Liver Transplants with Bioengineered Marrow Cells

  Levitsky, J. & Zhang, Z. J.

  Northwestern Memorial Foundation

  1/1/13 → 12/31/14

  Project: Research project

• Prot # VX11-950-117: A 2-Part, Open-Label Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Chronically Infected with Genotype 1 Hepatitis C Virus Following Liver Transplantation

  Levitsky, J.

  Vertex Pharmaceuticals Incorporated

  5/14/12 → 5/14/15

  Project: Research project

• Prot # VTR 10-03: The GORE® VIATORR® TIPS Endoprosthesis versus Large-Volume Paracentesis for the Treatment of Ascites in Patients with Portal Hypertension(Early TIPS for Ascites Study)

  Rinella, M. E., Flamm, S. L., Ganger, D. R., Green, R., Koppe, S. W. P., Kulik, L. M. & Levitsky, J.

  W. L. Gore and Associates

  4/19/11 → 3/1/13

  Project: Research project

• The Effects of Belatacept +/-Mycophenylate Moftil, Sirolimus or Basilixmab on Donor-Specific Tregs in the Treg MLR, BMS # IM 103-102

  Levitsky, J. & Mathew, J.

  Bristol-Myers Squibb Company

  11/8/10 → 11/8/13

  Project: Research project

• CAEB071B2201: A 24-month Randomized, Multicenter Study, Evaluating Efficacy, Safety, Tolerability and Pharmacokinetics of Sotrastaurin (STN) Combined with Tacrolimus (TAC) vs. a Tacrolimus/Mycophenolate Mofetil (MMF)-Based Control Regimen in De Novo Liver

  Levitsky, J.

  Novartis Pharmaceuticals Corporation

  3/22/10 → 9/30/13

  Project: Research project

• Proteogenomics for Organ Transplantation: Prediction, Diagnosis, Intervention

  Abecassis, M. M., Friedewald, J. J., Levitsky, J. & Sustento-Reodica, N.

  National Institute of Allergy and Infectious Diseases

  9/1/09 → 8/31/16

  Project: Research project

• Prot# 0468E6-4559: The Generation of Regulatory T-Cells in Mixed Lymphocyte Reactions After Conversion from Tacrollimus to Sirolimus in Liver Transplant Recipients

  Levitsky, J. & Mathew, J.

  Wyeth

  8/3/09 → 8/3/12

  Project: Research project

• The Generation of Regulatory T Cells in Mixed Lymphocyte Reactions After Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients

  Levitsky, J.

  Northwestern Memorial Foundation

  1/1/09 → 12/31/11

  Project: Research project

• Prot# HB-009: Evaluation of HepaGam B in Combination with Antiviral Treatment in Hepatitis B Liver Transplant Patients

  Levitsky, J.

  Cangene Corporation

  12/10/08 → 12/9/11

  Project: Research project

• Prot# IM103045: Evaluation of Belatacept as First-Line Immunosuppression in De Novo Liver Transplant Recipients

  Levitsky, J.

  Bristol-Myers Squibb Company

  9/2/08 → 9/2/11

  Project: Research project

• Prot# KV-08-001: The Differential Effects of 3 Different Immunosuppressive Agents, Tacrolimus, Mycophenolate Mofetil and Sirolimus on the Generation of Tregs and DCregs in In Vitro MLR and T Cell Activation Assays

  Gallon, L., Levitsky, J., Mathew, J., Miller, J. & Roitberg-Tambur, A.

  Astellas Pharma US, Inc

  7/24/08 → 7/23/09

  Project: Research project

• Immune Tolerance Profiles After Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients

  Levitsky, J.

  American Association for the Study of Liver Diseases

  7/1/08 → 8/30/10

  Project: Research project

• Prot# 0468E6-4479 / Version 1.0: Immune Tolerance Profiles After Conversion from Tacrolimus to Sirolimus After Liver Transplantation

  Levitsky, J., Abecassis, M. M., Mathew, J., Miller, J. & Roitberg-Tambur, A.

  Wyeth

  5/8/08 → 5/8/11

  Project: Research project

• Prot#: AI463109: Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection

  Levitsky, J.

  Bristol-Myers Squibb Company

  4/18/08 → 4/18/11

  Project: Research project

• Prot# ITN030ST: A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients

  Abecassis, M. M., Levitsky, J., Levitsky, J. & Abecassis, M. M.

  University of California, San Francisco, National Institute of Allergy and Infectious Diseases

  1/1/08 → 4/30/14

  Project: Research project

• Prot# UP 1203-003: A Phase 2, Randomized, Active-Controlled Study of the Safety & Efficacy of AMMONUL®(Sodium Phenylacetate & Sodium Benzoate) Injection 10%/10% in Patients with Grade III to IV Hepatic Encephalopathy

  Levitsky, J.

  Ucyclyd Pharma Inc.

  12/1/06 → 3/1/07

  Project: Research project

• Prot# ML18423: A Prospective, Open-Label, Multi-Center, Randomized Trial of the Efficacy and Safety of a Long Term Calcineurin Inhibitor Free Maintenance Regimen with Mycophenolate Mofetil and Sirolimus in Recipients of an Orthotopic Liver Transplant

  Levitsky, J., Abecassis, M. M., Baker, T. B., Fryer, J. P. & Kulik, L. M.

  Covance Periapproval Services, Inc., Roche Laboratories Inc.

  5/16/06 → 3/1/12

  Project: Research project

• Prot# P04590: PROTECT - Pegylated Interferon alfa-2b and Ribavirin After Orthotopic Liver Transplantation: Efficacy and Safety in Hepatitis C Recurrence Therapy

  Kulik, L. M., Abecassis, M. M. & Levitsky, J.

  Integrated Therapeutics Group, Inc.

  1/24/06 → 1/24/11

  Project: Research project